275 related articles for article (PubMed ID: 19319192)
1. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.
Lagirand-Cantaloube J; Cornille K; Csibi A; Batonnet-Pichon S; Leibovitch MP; Leibovitch SA
PLoS One; 2009; 4(3):e4973. PubMed ID: 19319192
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of atrogin-1/MAFbx expression by adenovirus-delivered small hairpin RNAs attenuates muscle atrophy in fasting mice.
Cong H; Sun L; Liu C; Tien P
Hum Gene Ther; 2011 Mar; 22(3):313-24. PubMed ID: 21126200
[TBL] [Abstract][Full Text] [Related]
3. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
4. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase.
Tintignac LA; Lagirand J; Batonnet S; Sirri V; Leibovitch MP; Leibovitch SA
J Biol Chem; 2005 Jan; 280(4):2847-56. PubMed ID: 15531760
[TBL] [Abstract][Full Text] [Related]
5. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.
Lagirand-Cantaloube J; Offner N; Csibi A; Leibovitch MP; Batonnet-Pichon S; Tintignac LA; Segura CT; Leibovitch SA
EMBO J; 2008 Apr; 27(8):1266-76. PubMed ID: 18354498
[TBL] [Abstract][Full Text] [Related]
6. Decreased muscle atrophy F-box (MAFbx) expression in regenerating muscle after muscle-damaging exercise.
Okada A; Ono Y; Nagatomi R; Kishimoto KN; Itoi E
Muscle Nerve; 2008 Oct; 38(4):1246-53. PubMed ID: 18785187
[TBL] [Abstract][Full Text] [Related]
7. Flavones Inhibit LPS-Induced Atrogin-1/MAFbx Expression in Mouse C2C12 Skeletal Myotubes.
Shiota C; Abe T; Kawai N; Ohno A; Teshima-Kondo S; Mori H; Terao J; Tanaka E; Nikawa T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):188-94. PubMed ID: 26052151
[TBL] [Abstract][Full Text] [Related]
8. Effect of dexamethasone on the expression of atrogin-1/MAFbx in chick skeletal muscle.
Nakashima K; Ishida A; Ijiri D; Ohtsuka A
Anim Sci J; 2016 Mar; 87(3):405-10. PubMed ID: 26279163
[TBL] [Abstract][Full Text] [Related]
9. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting.
Zhang G; Jin B; Li YP
EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090
[TBL] [Abstract][Full Text] [Related]
10. Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy.
Iyer CC; McGovern VL; Wise DO; Glass DJ; Burghes AH
Neuromuscul Disord; 2014 May; 24(5):436-44. PubMed ID: 24656734
[TBL] [Abstract][Full Text] [Related]
11. Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting.
Lokireddy S; Wijesoma IW; Sze SK; McFarlane C; Kambadur R; Sharma M
Am J Physiol Cell Physiol; 2012 Sep; 303(5):C512-29. PubMed ID: 22673621
[TBL] [Abstract][Full Text] [Related]
12. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
13. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.
Jin B; Li YP
J Cell Biochem; 2007 Mar; 100(4):960-9. PubMed ID: 17131360
[TBL] [Abstract][Full Text] [Related]
14. MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines.
Csibi A; Leibovitch MP; Cornille K; Tintignac LA; Leibovitch SA
J Biol Chem; 2009 Feb; 284(7):4413-21. PubMed ID: 19073596
[TBL] [Abstract][Full Text] [Related]
15. Expression of the muscle atrophy factor muscle atrophy F-box is suppressed by testosterone.
Zhao W; Pan J; Wang X; Wu Y; Bauman WA; Cardozo CP
Endocrinology; 2008 Nov; 149(11):5449-60. PubMed ID: 18599544
[TBL] [Abstract][Full Text] [Related]
16. Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase.
Jogo M; Shiraishi S; Tamura TA
FEBS Lett; 2009 Sep; 583(17):2715-9. PubMed ID: 19631210
[TBL] [Abstract][Full Text] [Related]
17. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
[TBL] [Abstract][Full Text] [Related]
18. Pyropia yezoensis peptide PYP1‑5 protects against dexamethasone‑induced muscle atrophy through the downregulation of atrogin1/MAFbx and MuRF1 in mouse C2C12 myotubes.
Lee MK; Kim YM; Kim IH; Choi YH; Nam TJ
Mol Med Rep; 2017 Jun; 15(6):3507-3514. PubMed ID: 28393223
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase kinase 1 (MEK1) stabilizes MyoD through direct phosphorylation at tyrosine 156 during myogenic differentiation.
Jo C; Cho SJ; Jo SA
J Biol Chem; 2011 May; 286(21):18903-13. PubMed ID: 21454680
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle.
Li YP; Chen Y; John J; Moylan J; Jin B; Mann DL; Reid MB
FASEB J; 2005 Mar; 19(3):362-70. PubMed ID: 15746179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
